biomarker detection
Genialis, PanCAN Partner to Validate Biomarker for KRAS-Inhibitor Response, Benefit
The collaboration will help validate the use of the Genialis KrasID panel to predict outcomes for pancreatic cancer patients who are treated with KRAS inhibitors.
APOE4 Homozygosity Constitutes Genetic Form of Alzheimer's Disease, Study Suggests
Previously, having two copies of the APOE4 allele was merely regarded as raising the risk of developing Alzheimer's disease, not causative.
Tagomics Raises £6.7M in Private Funding Round
The University of Birmingham spinout will use the funding to support R&D for its multiomic platform for finding biomarkers for cancer and other diseases.
Genialis, Cancer Research Horizons Partner to Predict Drug Responses
CRH will provide colorectal cancer datasets of diverse patient populations that Genialis will use to improve and validate its ResponderID platform.
Precede Biosciences Debuts Chromatin-Based Liquid Biopsy Platform Backed by New Data at ESMO
Premium
The firm has begun working with pharma, using its technology to identify and monitor transcriptionally regulated drug targets. It is also eyeing multiple clinical diagnostic applications.